Identification |
Name: | 1,4,8,11-Tetraazacyclotetradecane,1,1'-[1,4-phenylenebis(methylene)]bis-, hydrochloride (1:8) |
Synonyms: | 1,4,8,11-Tetraazacyclotetradecane,1,1'-[1,4-phenylenebis(methylene)]bis-, octahydrochloride (9CI);1,1'-[1,4-Phenylenebis(methylene)]bis-1,4,8,11-tetraazacyclotetradecane octahydrochloride; |
CAS: | 155148-31-5 |
Molecular Formula: | C28H54N8.8ClH |
Molecular Weight: | 502.78 |
InChI: | InChI=1/C28H54N8.8ClH.2H2O/c1-9-29-15-17-31-13-3-21-35(23-19-33-11-1)25-27-5-7-28(8-6-27)26-36-22-4-14-32-18-16-30-10-2-12-34-20-24-36;;;;;;;;;;/h5-8,29-34H,1-4,9-26H2;8*1H;2*1H2 |
Molecular Structure: |
|
Properties |
Density: | 0.962g/cm3 |
Biological Activity: | Highly selective CXCR4 chemokine receptor antagonist (IC 50 values are 0.02 - 0.13 and > 25 μ M for CXCR4 and all other chemokine receptors respectively). Switches inflammatory responses from Th2 to Th1 type and reduces airway hyperresponsiveness in a mouse model of asthma. Potently inhibits HIV-1 and HIV-2 replication in vitro (EC 50 = 4 - 35 nM) and mobilizes hematopoietic stem cells in vivo . |
Safety Data |
|
|